ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Geriatric Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

10,484Medicare Part D Prescriptions Filled, Including Refills

Rank: 18 out of 103

$628K Total Retail Price of All Prescriptions

Rank: 12 out of 103

773 Patients Receiving at Least One Drug in Part D
82%Patients 65 Years and Older
36% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Michigan
Lower avg

Schedule Two
Controlled Substances

11% of this provider’s 773 patients filled at least one prescription for a schedule two drug, compared to an average of 6%.

Schedule Three
Controlled Substances

18% of this provider’s 773 patients filled at least one prescription for a schedule three drug, compared to an average of 20%.

Risky Drugs to Seniors

1% of this provider’s 9,267 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 1%.

Brand Name Drugs

19% of this provider’s prescriptions were for brand-name drugs, compared to an average of 22%.

Prescription Price

$60 was the average price of a prescription from this provider, compared to $53 among peers.

Prescriptions per Patient

14 is the average number of prescriptions (including refills) per patient, compared to an average of 20.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Michigan
HYDROCODONE-ACETAMINOPHEN 479 358 S3 1 3
SIMVASTATIN 427 400 2 1
LISINOPRIL 427 393 2 2
OMEPRAZOLE 410 363 4 7
FUROSEMIDE 385 369 5 6
LEVOTHYROXINE SODIUM 295 276 6 4
AMLODIPINE BESYLATE 254 238 7 5
ZOLPIDEM TARTRATE 217 197 8 35
METOPROLOL SUCCINATE 215 203 9 17
METFORMIN HCL 214 179 10 14
METOPROLOL TARTRATE 198 184 11 8
CITALOPRAM HBR 184 161 12 10
PREDNISONE 181 171 13 38
HYDROCHLOROTHIAZIDE 159 135 14 15
WARFARIN SODIUM 151 143 15 9
ATENOLOL 137 132 16 19
TAMSULOSIN HCL 136 125 17 30
GLIMEPIRIDE 134 123 18 64
LOSARTAN POTASSIUM 117 109 19 23
AZITHROMYCIN 108 97 20 61
PRAVASTATIN SODIUM 104 96 21 27
FENTANYL 101 70 S2 22 48
DONEPEZIL HCL 101 101 22 11
CLOPIDOGREL 99 89 24 28
SPIRONOLACTONE 90 74 25 71
FLUTICASONE PROPIONATE 90 77 25 47
ALENDRONATE SODIUM 89 88 27 25
ISOSORBIDE MONONITRATE ER 89 89 27 26
SERTRALINE HCL 89 87 27 18
PLAVIX 89 86 27 44
SUCRALFATE 87 84 31 213
ESCITALOPRAM OXALATE 83 79 32 50
MORPHINE SULFATE 79 36 S2 33 139
METHADONE HCL 78 31 S2 34 106
KLOR-CON M20 74 68 35 73
ADVAIR DISKUS 73 64 36 43
DIGOXIN 72 61 37 49
TRIAMTERENE-HCTZ 72 71 37 83
TRAMADOL HCL 68 58 39 20
LORAZEPAM 67 66 40 182
CRESTOR 64 50 41 66
TRIAMCINOLONE ACETONIDE 63 59 42 108
ATORVASTATIN CALCIUM 62 55 43 21
NABUMETONE 61 54 44 196
ALLOPURINOL 61 58 44 36
POTASSIUM CHLORIDE 59 53 46 12
GABAPENTIN 58 52 47 13
LANTUS SOLOSTAR 55 53 48 93
PHENYTOIN SODIUM EXTENDED 54 36 49 112
LOVASTATIN 51 51 50 55
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on Jan. 18, 2008.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.